Advertisement

Topics

Companies Related to "A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis" [Most Relevant Company Matches] [Advanced Search Results] RSS

06:16 EDT 21st March 2019 | BioPortfolio

Here are the most relevant search results for "A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis" found in our extensive corporate database of over 50,000 company records.

Showing "Randomized Double Blind Protocol Comparing Amphotericin With Flucytosine" Companies 1–25 of 256

Extremely Relevant

Adeona Pharmaceuticals, Inc.

Adeona (AMEX: AEN) is a pharmaceutical company developing new medicines for serious central nervous systems diseases. Adeona's primary strategy is to in-license clinical-stage drug candidates that have already demonstrated a certain level of clinical efficacy and develop them to an inflection point in valuation resulting in a significant development and marketing collaboration. Trimesta (estriol) ...


Tricida, Inc.

Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of TRC101, a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with CKD. Metabolic acidosis is a condition commonly caused by CKD that is believed to accelerate the progression of kidney deterioration. Tricida has successfully...

Relevant

National Federation of the Blind (NFB)

With more than 50,000 members, the National Federation of the Blind is the largest and most influential membership organization of blind people in the United States. The NFB improves blind people’s lives through advocacy, education, research, technology, and programs encouraging independence and self-confidence. It is the leading force in the blindnes...


National Federation of the Blind

With more than 50,000 members, the National Federation of the Blind is the largest and most influential membership organization of blind people in the United States. The NFB improves blind people's lives through advocacy, education, research, technology, and programs encouraging independence and self-confidence. It is the leading force in the blindness field today and the voice of the nation's b...

National Federation of the Blind of Michigan

The National Federation of the Blind of Michigan is the state’s oldest and largest organization of blind consumers. Founded in 1941, we have chapters in most large cities in Michigan and provide advocacy, information about blindness, scholarships, and many other services that work toward our goal to change what it means to be blind in Michigan.

Favrille

We are a biopharmaceutical company focused on the development and commercialization of patient-specific immunotherapies for the treatment of cancer and other diseases of the immune system. We own a proprietary technology that enables us to efficiently develop and manufacture active immunotherapy products designed to stimulate a patient's own immune system to mount a specific and sustained response...

Celleration, Inc.

Celleration, Inc., a privately held medical device company, was founded in 1999 to develop and commercialize its therapeutic ultrasound platform. The patented MIST Technology delivers non-contact, low-frequency, low-intensity ultrasound to the patient's injured soft tissue in a painless fashion. The chronic diabetic foot ulcer market had been the Company's initial focus. MIST Therapy(R) has since ...

DOR BioPharma, Inc.

DOR BioPharma, Inc. (DOR) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. DOR's lead product, orBec(R) (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of GI GVHD, a comm...

Soligenix, Inc.

Soligenix, Inc. (Soligenix) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix's lead product, orBec(®) (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of acute ...

Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis. The Company has two broad platform technologies: dendritic cell-based vaccines and therapeutic antibodies. The Company is focusing on development ...

LifeWave Ltd

Incorporated in 2000, LifeWave Ltd. is a premier provider of innovative medical device in the field of Advanced Wound Management. The Company has developed an extensively researched and clinically-validated product that represents a truly novel approach in addressing the critical medical issue of chronic wounds care. LifeWave is currently focused on introducing its product to global markets. Chron...

Physician Hospitals of America

Comparing Medicare Expenditures on POHs and Non-POHs

InnoPharm Limited

InnoPharm Ltd. is an independent Russian domestic contract research organization providing Phase II-IV clinical trials support. InnoPharm was established in 1991 and operates in Russia (mainly its European part), Ukraine and Belarus. We also perform data management and statistical processing of data generated in clinical studies conducted all over the world and organize regular and ad-hoc GCP semi...

Protocol Online

Protocol Online is a database of research protocols in a variety of life science fields. It contains protocols contributed by worldwide researchers as well as links to web protocols hosted by worldwide research labs, biotech companies, personal web sites. The data is stored in a MySql relational database. Protocol Online also hosts discipline specific discussion forums (BioForum), and provides a f...

Santa Clara Valley Blind Center

For more than 50 years, SCVBC has provided support to individuals facing the uncertainties, fears, and challenges related to uncorrectable vision loss. We are a community-based organization dedicated to increasing the confidence, independence, and quality of life of the blind and visually impaired. SCVBC tackles complex vision loss issues comprehensively t...

Agennix

Agennix is a privately held biotechnology company whose lead molecule, Talactoferrin Alfa (talactoferrin; TLF), is an immunomodulatory protein. Agennix is currently preparing to initiate Phase III development of oral talactoferrin for cancer, and topical talactoferrin gel for wound healing.Liquid talactoferrin is an oral anti-cancer drug that has shown activity both as monotherapy and in combinati...

Sirna Therapeutics, Inc.

The scientific community considers RNA RNARibonucleic acid. A long chain polymer of genetic material similar to DNA except that it is usually found in a single-stranded form rather than as a double helix, it is made up of the ribo nucleotides A, G, C, and U (instead of T), it is somewhat less resistant to cellular degradation enzymes than DNA, and it functions most often as a transient messenger o...

Protocol Analytical Supplies Incorporated

Protocol manufactures the largest selection of Organic analytical calibration standards as well as offering Inorganic analytical calibration standards both stock and custom.

Quigley

Quigley is a leading marketer and developer of diversified natural health and homeopathic products including Cold-Eeze®, proven in two double blind studies to reduce the duration and severity of common cold symptoms. The company’s subsidiaries include Darius International Inc. and Caribbean Pacific Natural Products, Inc. Darius is a new direct selling organization specializing in proprietary h...

PROTOCOL Link, Inc.

PROTOCOL LINK was founded in January 1996 as a project management company providing comprehensive regulatory compliance, quality assurance and validation services to FDA-regulated firms worldwide.Our mission is to provide customer-focused consulting services with ethical conduct, mutual trust, and personnel empowerment

European Randomized Study of Screening for Prostate Cancer (ERSPC)

ERSPC (European Randomized Study of Screening for Prostate Cancer)

ProtoCOL HR

ProtoCOL HR is a high resolution automatic colony counting and zone sizing system, able to count extremely small colonies and measure zones with a very high degree of accuracy. This colony counter and zone sizer system offers incredibly accurate and repeatable results with superior performance for the most challenging of sample types and applications.

American Foundation for the Blind

Junior Blind of America


More From BioPortfolio on "A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks